Hexavalent Vaccine for Children Less Than 5 Years of Age Approved - PrecisionVaccinations

Hexavalent Vaccine for Children Less Than 5 Years of Age Approved  PrecisionVaccinations

The U.S. Food and Drug Administration (FDA) approved VAXELIS™ vaccine for use in children from 6 weeks through 4 years of age on December 21, 2018.